YJ1206
Product Specifications
CAS Number
3053716-98-3
Target
Apoptosis|||PROTACs|||CDK
Related Pathways
Apoptosis|||PROTAC|||Cell Cycle/Checkpoint
Purity
0.9714
Bioactivity
YJ1206 is a highly potent and selective CDK12/13 PROTAC degrader (IC50 =12.55 nM) with the advantages of oral administration and low toxicity, which triggers gene-length-dependent transcription elongation defects, leading to DNA damage and cell-cycle arrest, and inhibits the proliferation of a subpopulation of prostate cancer cells. YJ1206 can synergize with AKT pathway inhibitors to effectively inhibit prostate cancer.
Smiles
O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC(F)=C(C2)N4CCC(CC4)N5CCN(CC5)C6=CC=C(N(C(NCC7=CC=CC=C7)=O)[C@@H]8CC[C@@H](NC9=NC%10=C(C=N9)C=CC=C%10)CC8)C=N6
Molecular Formula
C49H52FN11O5
Molecular Weight
894.01
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15231787 1 Vial
Lentiviral mouse AU018091 shRNA (UAS) - Lentiviral mouse AU018091 shRNA (UAS) plasmid
Ask
View Details 
abx168194-01 10 µg
Human Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Protein
Ask
View Details abx168194-02 50 µg
Human Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Protein
Ask
View Details